Achyut Healthcare Share Price
6.95+0.05 (+0.72%)
+33.91% past 1 Year
Achyut Healthcare Limited is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium
Corporate filings & documents
Announcements
Newspaper Advertisement for financial result of quarter ended June 30 2026.
2 weeks agoNewspaper Advertisement for financial result of quarter ended June 30 2026.
2 weeks agoStatement of Deviation/Variation for quarter ended June 30 2026.
3 weeks agoStatement of Deviation/Variation for quarter ended June 30 2026.
3 weeks agoSubmission of Financial Result for the quarter ended June 30 2026
3 weeks agoSubmission of Financial Result for the quarter ended June 30 2026
3 weeks agoOutcome of Board Meeting held on August 13 2026
3 weeks agoOutcome of Board Meeting held on August 13 2026
3 weeks agoAchyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Friday August 13 2026
3 weeks agoAchyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Friday August 13 2026
3 weeks agoRevised outcome of Board Meeting held on held on Tuesday July 14 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act 2013.
1 month agoRevised outcome of Board Meeting held on held on Tuesday July 14 2026 and the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act 2013.
1 month agoAfter considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Section 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulations made thereunder read with Sections 2(6) of the Tax Act 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.
1 month agoAfter considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Section 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulations made thereunder read with Sections 2(6) of the Tax Act 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.
1 month agoAfter considering the recommendation of the Audit Committee and the Committee of Independent Director of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulation made thereunder read with Section 2(6) of the Income Tax 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.
1 month agoAfter considering the recommendation of the Audit Committee and the Committee of Independent Director of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulation made thereunder read with Section 2(6) of the Income Tax 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.
1 month agoOutcome of the Board Meeting held on Tuesday July 14 2026 and the disclosure pursuantto Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and intoZenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to232 and other applicable provisions of the Companies Act 2013
1 month agoOutcome of the Board Meeting held on Tuesday July 14 2026 and the disclosure pursuantto Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and intoZenith Healthcare Limited and their respective shareholders and creditors under Sections 230 to232 and other applicable provisions of the Companies Act 2013
1 month agoCompliance -Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018
1 month agoCompliance -Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018
1 month agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoPaper Cutting of Published Audited Financial Result for the Quarter and Year ended 31st March 2026
3 months agoSubmission of Statement of Deviation or Variation for proceeds of public issue pursuant to Regulation 32 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 for the year ended on 31st March 2026
3 months agoSubmission of Statement of Deviation or Variation for proceeds of public issue pursuant to Regulation 32 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 for the year ended on 31st March 2026
3 months agoOutcome of Board Meeting General update
3 months agoAppointment of Internal Auditor for the Financial Year 2026-27 Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015.
3 months agoStandalone Audited Financial Result for the quarter and year ended on 31.03.2026
3 months agoStandalone Audited Financial Result for the quarter and year ended on 31.03.2026
3 months agoStandalone Audited Financial Result for the Quarter and Year ended on 31.03.2026.
3 months agoStandalone Audited Financial Result for the Quarter and Year ended on 31.03.2026.
3 months agoOutcome of Board Meeting of Board of Directors held on 27th May 2026 Consideration and Approval Audited Financial Result for the Quarter ended 31st March 2026
3 months agoOutcome of Board Meeting of Board of Directors held on 27th May 2026 Consideration and Approval Audited Financial Result for the Quarter ended 31st March 2026
3 months agoAchyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Achyut Healthcare Limited informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve We hereby inform you that the Board of Directors Meeting of Achyut Healthcare Limited is scheduled to be held on Wednesday May 27th 2026 at the registered office of the Company.
3 months agoAchyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Achyut Healthcare Limited informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve We hereby inform you that the Board of Directors Meeting of Achyut Healthcare Limited is scheduled to be held on Wednesday May 27th 2026 at the registered office of the Company.
3 months agoAchyut Healthcare Limited herewith submit Annual Secretarial Compliance Report for year ended 31st March 2026.
3 months agoAchyut Healthcare Limited herewith submit Annual Secretarial Compliance Report for year ended 31st March 2026.
3 months agoDisclosure for Listing Approval received under Preferential Issue
3 months agoDisclosure for Listing Approval received under Preferential Issue
3 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Achyut Healthcare Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L67120GJ1996PLC028600</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2024-25 2025-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Kaushalkumar Dave</td></tr><tr><td>Designation :-</td><td>Company Secretary </td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Jigen J Modi</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 20/04/2026<br/><br/></div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Achyut Healthcare Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L67120GJ1996PLC028600</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2024-25 2025-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Kaushalkumar Dave</td></tr><tr><td>Designation :-</td><td>Company Secretary </td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Jigen J Modi</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 20/04/2026<br/><br/></div>
4 months agoCertificate Under Reg.74(5) of SEBI (DP) Regulations 2018
4 months agoCertificate Under Reg.74(5) of SEBI (DP) Regulations 2018
4 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Akshit Raycha
5 months agoIntimation for Trading Window Closure
5 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Zenith Life Care Pvt Ltd
5 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ray Remedies Pvt Ltd
5 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahendra Raycha HUF
5 months agoDisclosure for Allotment of Equity Shares under Preferential Issue
5 months agoDisclosure for Allotment of Equity Shares under Preferential Issue
5 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2024-12-10
Bonus
4:10
2024-12-10
Split
10:1
2023-04-25
Bonus
1:2
Company details
Registered office
504, Iscon Elegance Circle P S. G. Highway Ahmedabad Gujarat PIN: 380015 Tel No: 079 4898 2691 / 9825097076 / 9898986846 Fax No: NULL Email: [email protected] Internet: www.achyuthealthcare.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Jigen Jagdishbhai Modi, Managing Director
Mahendra C Raycha, Chairman
Akshit Raycha, Promoter & Non-Executive Director
Amisha Jigen Modi, Executive Director
Rutvik Sanjaykumar Thakkar, Non Executive Independent Director
Sonu Jain, Non Executive Independent Director
Parag Dave, Non Executive Independent Director
Rajesh C Sutaria, Non Executive Independent Director
Kaushalkumar Shrikrishnabhai Dave, Company Secretary & Compliance Officer
Details
BSE 543499
NSE NULL
ISIN INE0K1401020